Hikma Pharmaceuticals PLC
LSE:HIK

Watchlist Manager
Hikma Pharmaceuticals PLC Logo
Hikma Pharmaceuticals PLC
LSE:HIK
Watchlist
Price: 1 794 GBX -0.83% Market Closed
Market Cap: 4B GBX
Have any thoughts about
Hikma Pharmaceuticals PLC?
Write Note

Hikma Pharmaceuticals PLC
Cash

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Hikma Pharmaceuticals PLC
Cash Peer Comparison

Comparables:
GSK
AZN
VRNA
INDV
DPH

Competitive Cash Analysis
Latest Figures & CAGR of Competitors

Company Cash CAGR 3Y CAGR 5Y CAGR 10Y
Hikma Pharmaceuticals PLC
LSE:HIK
Cash
$133m
CAGR 3-Years
-18%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
GlaxoSmithKline PLC
LSE:GSK
Cash
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
AstraZeneca PLC
LSE:AZN
Cash
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Verona Pharma PLC
NASDAQ:VRNA
Cash
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Indivior PLC
LSE:INDV
Cash
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Dechra Pharmaceuticals PLC
LSE:DPH
Cash
ÂŁ74.4m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A

See Also

What is Hikma Pharmaceuticals PLC's Cash?
Cash
133m USD

Based on the financial report for Jun 30, 2024, Hikma Pharmaceuticals PLC's Cash amounts to 133m USD.

What is Hikma Pharmaceuticals PLC's Cash growth rate?
Cash CAGR 3Y
-18%

Over the last year, the Cash growth was 18%. The average annual Cash growth rates for Hikma Pharmaceuticals PLC have been -18% over the past three years .

Back to Top